KLK3 and prostate cancer: We retrospectively reviewed data of 233,554 prostate cancer patients in the Surveillance, Epidemiology and End Results (SEER) program and of 199 prostate cancer patients from the medical records of the Affiliated Hospital of Qingdao University with PSA ≤10 ng/mL at diagnosis.